TSS
AUTL

Two Sigma Securities’s Autolus Therapeutics AUTL Stock Holding History

Two Sigma Securities’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-43,462
Closed -$60K – 1727
2026
Q1 		$60K Sell
43,462
-23,117
-35% -$35.1K 0.01% 1245
2025
Q4 		$132K Buy
+66,579
New +$102K 0.02% 934
2025
Q3 		– Sell
-10,001
Closed -$22.8K – 1390
2025
Q2 		$22.8K Buy
+10,001
New +$16.5K ﹤0.01% 1189

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Securities's AUTL Position: Q2 2026 in Review

Two Sigma Securities sold out of Autolus Therapeutics (AUTL) in Q2 2026, closing a stake of 43,462 shares — an estimated $60K sold.

Two Sigma Securities first reported a position in AUTL in Q2 2025 and held it in 3 quarters. The position peaked at $132K in Q4 2025. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • Two Sigma Securities reported no remaining Autolus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 43,462 Autolus Therapeutics shares in Q2 2026, an estimated $60K.
  • Two Sigma Securities first reported a position in Autolus Therapeutics in Q2 2025 and held it in 3 quarters.
  • Two Sigma Securities's Autolus Therapeutics position peaked at $132K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.